What Cell & Gene does

Cell & Gene is a B2B media and content platform serving the cell and gene therapy (CGT) industry, operated as a publication brand under VertMarkets, Inc., a life science B2B media conglomerate headquartered in Erie, Pennsylvania. The platform delivers industry-specific editorial covering CGT manufacturing, vectors, formulation, fill-finish, cold chain management, and quality control, and serves pharmaceutical and biotech developers, contract development and manufacturing organizations (CDMOs), and equipment and service suppliers operating in the advanced therapies space. Cell & Gene positions itself as a centralized information hub for a fast-growing and technically complex sector, with the global CGT market projected to reach $28.05 billion by 2031 at a 25.8% CAGR.

The core product is a multi-channel content portfolio: a free weekly email newsletter, the on-demand STREAM Video Channel, Cell & Gene Live virtual events, the Cell & Gene: The Podcast audio series, the annual Cell & Gene Tech Expo, cur ated Content Collections, and Sourcing Centers — a B2B directory platform connecting developers with service providers across clinical trial services, manufacturing, regulatory, supply chain, outsourcing, and translational research categories. The underlying technology is a web-based content management and digital publishing platform, and the brand is embedded within the broader Life Science Connect network of 12+ peer B2B publications that cross-promote content and share audience reach.

The business model is advertising- and sponsorship-supported rather than subscription-based. Revenue is generated primarily from display advertising and sponsored content sold to CGT industry suppliers, CDMOs, and life science service providers; from event sponsorships and registrations (CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, Tech Expo); and from supplier directory listings on the Sourcing Centers. The free newsletter serves as audience-building and lead-generation infrastructure, creating the reach that advertisers and sponsors purchase against.

Name

Cell & Gene

Legal name

VertMarkets, Inc.

Website

https://cellandgene.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry, delivering editorial articles, newsletters, podcasts, video, virtual events, and a sourcing directory to CGT developers, CDMOs, and life science suppliers, monetized through advertising, sponsorships, and event registrations.

Ownership category

akta.pro rank

Headquarters

HQ city

Erie

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Advertising & Sponsorship Revenue: Cell & Gene generates revenue primarily through advertising and sponsorship from life science industry suppliers, CDMOs, equipment manufacturers, and service providers seeking to reach the CGT professional audience. The platform offers premier advertiser partnerships and media kit options for companies wanting to promote their products and services to the industry.
2. Newsletter Subscription (Free to Readers): The company offers free newsletter subscriptions to industry professionals as a lead generation and audience building mechanism. This free model drives audience growth and creates advertising inventory for sponsors targeting the CGT industry.
3. Event Sponsorships and Registrations: Revenue generated from sponsored sessions, booth placements, and registrations at owned events including CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, and the Cell & Gene Tech Expo.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Cell & Gene is a B2B media and content platform dedicated to the cell and gene therapy industry. It publishes editorial articles, technical guides, white papers, a weekly email newsletter, on-demand video content, a podcast, and live virtual events, and hosts an annual expo plus Sourcing Center B2B directories for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research services. Revenue is generated through advertising, sponsorships, and event participation by CDMOs, equipment manufacturers, and life science service providers targeting CGT professionals.

Product overview

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry. The platform operates as a unified offering combining multiple content channels: the Cell & Gene Newsletter (weekly industry insights), STREAM Video Channel (on-demand webinars), Cell & Gene Live (virtual events), Cell & Gene: The Podcast (audio discussions), and Cell & Gene Tech Expo (annual conference). The platform also hosts Content Collections (curated editorial packages) and Sourcing Centers (B2B directories connecting manufacturers with service providers for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research). The site publishes educational topic pages covering CGT Vectors, Cell Therapy Manufacturing, Gene Therapy Manufacturing, Formulation, Fill-Finish, Quality Assurance, and Cold Chain Management.

Differentiator

Problem solved

Functional benefit

Brands

• STREAM Video Channel: Video content platform featuring webinars and educational content on cell and gene therapy manufacturing and development
• Cell & Gene Live
• Cell & Gene: The Podcast
• Cell & Gene Tech Expo

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• VertMarkets, Inc.coreOthersVertMarkets, Inc. is the parent company and publisher of Cell & Gene. The company operates as part of the VertMarkets media network, which has been serving the life science industry since 1996. VertMarkets publishes multiple B2B industry publications across pharmaceutical, biotech, medical device, and life science sectors.
• Life Science Connect NetworkcoreStrategic or Co-development PartnerThe Life Science Connect network is a consortium of B2B publications serving the life science industry, including Cell & Gene, Advancing RNA, Bioprocess Online, Biosimilar Development, Clinical Leader, Clinical Supply Leader, Drug Delivery Leader, Drug Discovery Online, Life Science Leader, Med Device Online, Outsource Pharma, and Pharmaceutical Online. These publications cross-promote content and share audience reach to benefit member publications and their advertisers.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Endpoints News: Independent B2B news outlet covering the biopharma industry with significant overlap into cell and gene therapy reporting, manufacturing, and CDMO deal coverage. Direct competitor for CGT professional audience attention and biopharma advertising dollars.
• GEN (Genetic Engineering & Biotechnology News): Long-running B2B publication covering biotechnology, with extensive cell and gene therapy editorial coverage including manufacturing, vectors, and bioprocessing. Direct competitor for the same CGT professional subscriber and advertiser base.
• BioPharma Dive: Industry publication covering biopharma business, R&D, and manufacturing trends including CGT. Comparable B2B media model relying on advertising, newsletters, and events for the same life science professional audience.
• Fierce Biotech: Major biopharma trade publication covering clinical development, manufacturing, and deal activity in cell and gene therapy. Competes directly for CGT professional readership and advertising spend.
• BioSpace: Life sciences industry news and career platform with dedicated CGT manufacturing and bioprocessing coverage. Comparable B2B media + community model serving the same hiring and product-awareness audiences.
• BioProcess International (BPI): Vertically-focused B2B publication and conference series covering bioprocessing, including cell and gene therapy manufacturing. Most direct overlap in CGT manufacturing editorial and CDMO audience.

Broad incumbents

• Outsourced Pharma: Sister publication within the same Life Science Connect / VertMarkets network. Covers contract manufacturing and outsourcing broadly across pharma, including CGT, and shares audiences and advertiser pools with Cell & Gene.
• Drug Discovery Online: Sister publication within the Life Science Connect network covering drug discovery, with adjacent CGT therapeutic content. Comparable business model and shared cross-promotion.
• Life Science Leader: VertMarkets/Life Science Connect publication covering the broader life science executive audience, including CGT operations. Comparable B2B media model within the same parent network.

Regional players

• PharmaTimes: UK-based B2B pharma publication covering manufacturing, clinical development, and industry trends including CGT. Comparable B2B media format but primarily focused on European audiences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/showcase/cell-&-gene
• Xx.com/_CellandGene
• Facebookfacebook.com/Cell-Gene-100076517977598

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell & Gene